Soraia holds a Bachelor's degree in Applied Biology and a Master's degree in Molecular Genetics from the University of Minho (Braga, Portugal). The bachelor’s research project aimed at evaluating different nanoliposomes as drug delivery systems. Currently, she
has a Master research grant by Foundation for Science and Technology – Portugal (FCT)
within the project “N2BD - Development of a Novel Nose-to-Brain multifunctional nanoplatform for the treatment of Depression and prevention of pharmacoresistance development” (ref. CENTRO-01-0145-FEDER-030752 and POCI-01-0145-FEDER-030478)
at Laboratory of Pharmacology and Pharmaceutical Care from the Faculty of Pharmacy of University of Coimbra (Portugal). At the present, she is developing high performance liquid chromatography methods to quantify antidepressant drugs in biological samples
and in vivo and in vitro assays to predict and describe the pharmacokinetics and pharmacodynamics of antidepressant drugs. Recently, she wrote a review regarding Antidepressants and nose-to-brain delivery: published in Drug Discovery Today 2019.